BeOne Medicines AG (ONC) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $39.40B, a trailing price-to-earnings ratio of 61.3 and a free-cash-flow yield of 2.2%. Over the most recent reported fiscal year, revenue grew 40.2%.